SAR1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.659040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.057030E-01
Normal-vs-Stage2
1.315410E-01
Normal-vs-Stage3
8.116400E-01
Normal-vs-Stage4
1.709840E-01
Stage1-vs-Stage2
2.562000E-01
Stage1-vs-Stage3
8.345900E-02
Stage1-vs-Stage4
8.537800E-01
Stage2-vs-Stage3
1.241560E-01
Stage2-vs-Stage4
5.153400E-01
Stage3-vs-Stage4
1.425180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.784840E-01
Normal-vs-AfricanAmerican
7.830000E-02
Normal-vs-Asian
2.795200E-01
Caucasian-vs-AfricanAmerican
3.219600E-01
Caucasian-vs-Asian
6.742600E-01
AfricanAmerican-vs-Asian
6.610000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.619770E-01
Normal-vs-Female
1.749570E-01
Male-vs-Female
5.112200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.679410E-01
Normal-vs-Age(41-60Yrs)
9.942400E-02
Normal-vs-Age(61-80Yrs)
1.984950E-01
Normal-vs-Age(81-100Yrs)
3.683800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.717200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.953000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.223000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.222080E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.463000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.759200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.196600E-01
Normal-vs-Daily Drinker
2.368200E-01
Normal-vs-Weekly Drinker
3.729000E-01
Normal-vs-Occasional Drinker
1.000200E-01
Normal-vs-Social Drinker
2.906600E-01
Non Drinker-vs-Daily Drinker
3.144600E-01
Non Drinker-vs-Weekly Drinker
4.813800E-01
Non Drinker-vs-Occasional Drinker
2.982800E-01
Non Drinker-vs-Social Drinker
5.271000E-01
Daily Drinker-vs-Weekly Drinker
9.256000E-01
Daily Drinker-vs-Occasional Drinker
4.109700E-02
Daily Drinker-vs-Social Drinker
2.509600E-01
Weekly Drinker-vs-Occasional Drinker
1.309820E-01
Weekly Drinker-vs-Social Drinker
3.273600E-01
Occasional Drinker-vs-Social Drinker
8.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.388750E-01
Normal-vs-Grade 2
8.921000E-03
Normal-vs-Grade 3
7.102800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.790400E-01
Grade 1-vs-Grade 3
7.147800E-01
Grade 1-vs-Grade 4
1.388750E-01
Grade 2-vs-Grade 3
8.477400E-01
Grade 2-vs-Grade 4
8.921000E-03
Grade 3-vs-Grade 4
7.102800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.572200E-01
Normal-vs-NonDiabetic
1.885630E-01
Diabetic-vs-NonDiabetic
3.120000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.568820E-01
Normal-vs-NoPancreatitis
2.075800E-01
Pancreatitis-vs-NoPancreatitis
8.455800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.282200E-01
Normal-vs-N1
1.314160E-01
N0-vs-N1
3.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.845500E-02
Normal-vs-TP53-NonMutant
1.901350E-01
TP53-Mutant-vs-TP53-NonMutant
6.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
